Skip to main content
The Entrepreneur Story logoThe Entrepreneur Story
BUSINESS·1 min read·May 14, 2026

B2B automobile spares startup Koovers has raised $1.5 million

B2B automobile spares startup Koovers has raised $1.5 million driven by Inflection Point Ventures (IPV), JPIN-VCats and Venture Catalysts. According to the Delhi-based startup, the assets will be utilized to expand its presence across India, expand its product portfolio, and upgrade its innovation p

A mechanic focuses on car engine repair in outdoor setting, showcasing precision.
A mechanic focuses on car engine repair in outdoor setting, showcasing precision. · Plate 01 · Photographed for The Entrepreneur Story

B2B automobile spares startup Koovers has raised $1.5 million driven by Inflection Point Ventures (IPV), JPIN-VCats and Venture Catalysts.

According to the Delhi-based startup, the assets will be utilized to expand its presence across India, expand its product portfolio, and upgrade its innovation platform.

Established in 2016 by Vinayak YB, Sandeep Begur and S Prem Kumar, Koovers centers around supplying genuine spare parts to independent auto workshops and the aftermarket biological system including ordering and doorstep delivery.

The startup has over 5,000 workshops in its network. Notwithstanding the COVID-19 lockdown, it claims to have timed 100% annual growth with $4.5 million ARR.

Koovers is the 36th deal for IPV in 2021. According to the VC firm, it has so far invested Rs 292 crore across 98 deals and is probably going to invest Rs 155 crore this year across more than 60 startups.

operatorsfounders2026

Continue reading

Blurred abstract image of a microchip with heatmap colors highlighting technological innovation.
Capital

Anthropic IPO: Trillion-Dollar Ambition, AI Warnings A Founder's Ethical Dilemma

Autonomous delivery robot navigating indoors during a technology event.
Startup News

Shopify Unlocks AI Agent Commerce: A New E-commerce Frontier *Implications for Startups*

Close-up of robotic arm automating lab processes with precision.
Capital

OpenAI Leads $153M Funding for AI Drug Discovery Startup Biossil

The Entrepreneur Story

Is your story worth telling?

We feature founders who are building something real. Apply and we'll be in touch.

Apply to be featured →